Award Type [Axis]
Employee Stock Option [Member]
Class of Stock [Axis]
Series A Convertible Preferred Stock [Member]
Series B Convertible Preferred Stock [Member]
Warrant [Member]
Debt Instrument [Axis]
Series A Notes Payable Due At Maturity In October 2011 (Past Due) [Member]
Nonvested Stock Options [Member]
Restricted Stock [Member]
Title of Individual [Axis]
Director [Member]
Antidilutive Securities [Axis]
Stock Options [Member]
Preferred share agreements [Member]
Finite-Lived Intangible Assets by Major Class [Axis]
Patents [Member]
Trademarks [Member]
Range [Axis]
Minimum [Member]
Maximum [Member]
Patents And Trademark [Member]
Notes Payable [Member]
Class of Warrant or Right [Axis]
Equity Components [Axis]
Common Stock [Member]
Common Stock payable [Member]
Stock Options, Restricted Stock and Units, and Other Stock-based Awards [Member]
Plan Name [Axis]
Stock Option 2013 Plan [Member]
Restricted Stock Units (RSUs) [Member]
Consulting service agreement [Member]
Board of Director [Member]
Consultant [Member]
Sale of Stock [Axis]
Private Placement [Member]
Common stock and warrant [Member]
Related Party [Axis]
Settlement Agreement [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Former Chief Executive Officer [Member]
Chairman of Board [Member]
Officer [Member]
Related Party Transaction [Axis]
Related Party [Member]
Third Party [Member]
New Director [Member]
Klapper [Member]
Warrant discount program [Member]
Member of Board [Member]
Document And Entity Information [Abstract]
Document Type
Amendment Flag
Document Period End Date
Document Fiscal Year Focus
Document Fiscal Period Focus
Trading Symbol
Entity Registrant Name
Entity Central Index Key
Current Fiscal Year End Date
Entity Filer Category
Entity Common Stock, Shares Outstanding
Statement [Table]
Statement [Line Items]
ASSETS
CURRENT ASSETS
Cash and cash equivalents
Prepaid expenses and other current assets
Accounts receivable
Inventory
TOTAL CURRENT ASSETS
PROPERTY AND EQUIPMENT
Capital equipment, net of accumulated depreciation of $203,223 as of March 31, 2018 and December 31, 2017
OTHER ASSETS
Patents and Trademarks, net of accumulated amortization of $242,365 and $237,331 as of March 31, 2018 and December 31, 2017
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS' DEFICIT
CURRENT LIABILITIES
Accounts payable and accrued expenses
Customer deposits
Notes payable
Common stock payable
TOTAL CURRENT LIABILITIES
CONTINGENCIES
STOCKHOLDERS' EQUITY (DEFICIT)
Convertible Preferred Stock
Common stock of $.001 par value; 675,000,000 authorized; 92,945,925 and 53,873,872 issued, 92,595,385 and 53,523,332 shares outstanding as of March 31, 2018 and December 31, 2017
Additional paid in capital
Treasury stock as cost (350,540 shares at March 31, 2018 and December 31, 2017)
Deferred compensation
Accumulated deficit
STOCKHOLDERS' EQUITY (DEFICIT)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Series C Convertible Preferred Stock [Member]
Series D Convertible Preferred Stock [Member]
Accumulated depreciation on capital equipment
Accumulated amortization, patent and trademarks
Net of discount on note payable
Preferred stock, par value
Preferred stock, shares authorized
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Treasury stock, shares
Income Statement [Abstract]
NET REVENUES
Sales
Royalties
TOTAL NET REVENUE
COST OF SALES
GROSS PROFIT
OPERATING EXPENSES
General and administrative
Legal and accounting
Payroll expenses
Research and development
Sales and marketing
Total operating expenses
LOSS BEFORE OTHER INCOME (EXPENSE)
OTHER (EXPENSE) INCOME
Interest expenses, net
Settlement agreement with shareholders
Gain on accounts payable forgiveness
Change in fair value of warrants
Change in fair value of embedded derivative liability
TOTAL OTHER INCOME (EXPENSE)
NET LOSS
LOSS PER SHARE
BASIC
DILUTED
WEIGHTED AVERAGE COMMON SHARE OUTSTANDING
BASIC
DILUTED
Share related payments
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Stock based compensation
Fair value of options and warrants issued in exchange for services
Fair value of restricted stock and restricted stock units issued in exchange for services
Gain on accounts payable forgiveness
Share-based payment for settlement agreement with shareholders
Accretion of discount on notes payable
Change in fair value of warrant liability
Change in fair value of embedded derivative liability
Amortization and depreciation
Reversal of expense from forfeiture of restricted stock
Amortization of deferred compensation
Changes in operating assets and liabilities:
Inventory
Prepaid expenses and other current assets
Accounts payable and accrued expenses
Net cash used in operating activities
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of patents
Net cash used in investing activities
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of related party notes payable
Proceeds from exercise of warrants
Proceeds from sale of common stock
Net cash provided by financing activities
NET INCREASE IN CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD
CASH AND CASH EQUIVALENTS - END OF PERIOD
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid during the year for: Interest
Cash paid during the year for: Income taxes
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Convertible Preferred Stock converted to common stock
Cashless Exercise of Stock Options
Security deposit offset against accounts payable
Accretion of discount on preferred stock as deemed dividend distribution
Deemed dividend distribution on issuance of common stock for conversion of Series C and Series D
Revaluation of restricted stock units additional paid in capital and deferred compensation
Forfeited restricted common stock
Revaluation of embedded derivative liability upon conversion of Convertible Preferred Stock
Revaluation of warrant liability upon conversion Convertible Preferred Stock
Common Stock and Warrants Issued for Common Stock Payable
Warrants issued as discount to notes payable
Conversion of accounts payable and accrued expenses to common stock
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Goodwill and Intangible Assets Disclosure [Abstract]
Patents and Trademark
Income Tax Disclosure [Abstract]
INCOME TAXES
Notes Payable [Abstract]
NOTES PAYABLE
CONVERTIBLE PREFERRED STOCK [Abstract]
CONVERTIBLE PREFERRED STOCK
Equity [Abstract]
Stockholders' Equity
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock Options and Warrants
Related Party Transactions [Abstract]
RELATED PARTIES
Debt Forgiveness
DEBT FORGIVENESS
Subsequent Events [Abstract]
SUBSEQUENT EVENTS
Nature of Business
Basis of Presentation
Reclassifications
Basic and Diluted Net Income per Share of Common Stock
Recently Adopted Accounting Pronouncements
Recently Issued Accounting Pronouncements Not Yet Adopted
NOTES PAYABLE
Schedule of Weighted-average Assumptions Used to Estimate the Fair Values of Stock Options Granted
Schedule of Stock Option Activity
Summary of the Activities of Unvested Stock Options
Schedule of Warrant Activity
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents, excluded from the calculation of earnings per share
Schedule of Finite-Lived Intangible Assets [Table]
Finite-Lived Intangible Assets [Line Items]
Geographical [Axis]
Number of patents granted
Number of trademarks
Number of new patent
Estimated lives of intangible assets
Amortization method
Capitalized patent costs and trademarks
Amortization expense
Income Tax Expense (Benefit)
Unrecognized tax benefits
Interest or penalties related to unrecognized tax benefits
Change in unrecognized tax benefits
Accrual for uncertain tax positions
Schedule of Long-term Debt Instruments [Table]
Debt Instrument [Line Items]
Long-term Debt, Type [Axis]
Transaction Type [Axis]
Expected dividend yield
Expected volatility
Risk-free interest rate
Expected warrant term
Proceeds from issuance of notes payable
Debt conversion, converted amount
Shares issued on conversion of debt (in shares)
Investment in common stock
Number of common stock called by warrants (in shares)
Exercise price (in dollars per share)
Fair value of warrant liability
Accumulated discount, notes payable (in dollars)
Interest expense
Interest rate, notes payable
Note payable balance
Accrued interest
Pre reverse split shares issued on conversion of debt (in shares)
Pre reverse stock split share price
Gain recorded in additional paid in capital
Gain (loss) on extinguishment of debt
Repayment of notes payable
Number of common stock called by warrants
Note due date
Warrant value
Interest expense including accretion of debt discount
Loss on settlement of related party notes payable
Increase decrease in notes payable
Notes payable
Less: Unamortized discount
Less: Current portion
Balance
Interest rate
Schedule of Stock by Class [Table]
Class of Stock [Line Items]
Conversion of Stock, Shares Converted
Conversion of shares of preferred stock to common stock, shares
Shares of convertible preferred stock issued
Shares issued to convert accounts payable
Shares issued to convert accounts payable, value
Remaining shares converted
Common stock issued
Common stock sold
Proceeds From Issuance Of Convertible Preferred Stock
Issuance costs of stock
Conversion of Stock, value Converted
Exercise price
Option foreited to purchase common stock
Restricted stock units, Expense
Restricted stock units issued
Restricted stock units fair value
Restricted stock awards granted
Restricted stock awards granted term
Proceeds From Issuance of Private Placement
Warrant term
Issuance of shares cashless exercise of options related to services
Disposed shares related to services
Warrants exercisable Price
Amount of Settlement paid
Option vesting
Stock issued
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized to be granted under plan
Exercise price, description
Option, expense
Intrinsic value of stock options exercised
Unamortized option expense
Vested
Granted
Shares issued during period value
Shares issued during period
Shares issued in conversion of debt
Forfeited warrants
Warrants exercised
Risk Free Interest Rate
Expected Volatility
Expected Life (in years)
Dividend Yield
Weighted average estimated fair value of options during the period
Number of Shares:
Balance, beginning
Expired/Cancelled
Exercised
Forfeited/cancelled
Expired
Balance, ending
Exercisable
Exercisable as of March 31, 2018 and expected to vest thereafter
Weighted Average Exercise Price:
Balance, beginning
Expired/Cancelled
Granted
Exercised
Forfeited/cancelled
Expired
Balance, ending
Exercisable
Exercisable as of March 31, 2018 and expected to vest thereafter
Weighted Average Remaining Contractual Term:
Balance as of March 31, 2018
Exercisable as of March 31, 2018
Exercisable as of March 31, 2018 and expected to vest thereafter
Aggregate Intrinsic Value:
Balance as of March 31, 2018
Exercisable as of March 31, 2018
Exercisable as of March 31, 2018 and expected to vest thereafter
Number of Shares
Balance, Beginning
Vested
Cancelled/forfeited/expired
Balance, Ending
Weighted-Average Grant Date Fair Value
Balance, Beginning
Granted
Vested
Cancelled/forfeited/expired
Balance, Ending
Number of Shares:
Balance, beginning
Issued
Granted
Exercised
Expired
Cancelled/Forfeited
Balance, ending
Exercisable at March 31, 2018
Exercisable as of March 31, 2018 and expected to vest thereafter
Weighted Average Exercise Price:
Balance, beginning
Issued
Expired
Granted
Exercised
Forfeited/canceled
Outstanding, ending
Exercisable at March 31, 2018
Exercisable as of March 31, 2018 and expected to vest thereafter
Weighted- Average Remaining Contractual Term:
Balance as of March 31, 2018
Exercisable as of March 31, 2018
Exercisable as of March 31, 2018 and expected to vest thereafter
Aggregate Intrinsic Value:
Balance as of March 31, 2018
Exercisable as of March 31, 2018
Exercisable as of March 31, 2018 and expected to vest thereafter
Closing stock price
Due from related party
Due to related party
Debt Forgiveness Details
Gain on accounts payable forgiveness
Subsequent Event [Table]
Subsequent Event [Line Items]
Proceeds from warrant
Vesting restricted common stock
Amount of accretion of discount on preferred stock as deemed dividend distribution.
Accumulated Deficit During Developments Stage [Member]
Adjustment [Member]
Agreements [Axis]
Agreements [Member]
The amount of amortization and depreciation or (credit) during the period.
Represents change in fair value of embedded derivative liability during the year.
Represents the amount of expense (income) related to adjustment to fair value of warrant liability.
Represents Change in fair value of warrants.
Common stock and warrant [Member]
Common stock subscription.
Consultant and stockholder [Member]
Consultant [Member]
Consulting fees [Member]
Conversion of accounts payable and accrued expenses into common stock.
Convertible Preferred Stock Issued During Period Shares New Issues
Debt conversion converted instrument pre reverse split share price.
Debt conversion converted instrument pre reverse split shares.
Debt Instrument Date Five August 2014 [Member]
Document And Entity Information [Abstract]
Employee Stock Option One [Member]
Represent amount of fair value of option issue in exchange for services.
Financing [Member]
Amount of interest expense including accretion of debt discount.
Loan [Member]
Nature Of Business Policy.
Represents the information pertaining to unvested stock options.
Notes Payable Due At Maturity In June 30, 2017 [Member]
Notes Payable Due Junel Thirty Thousand Seventeen [Member]
Notes Payable [Member]
Notes Payable One Due Junel Thirty Thousand Seventeen [Member]
This element represent payroll expenses.
Payroll Expenses [Member]
Post Reverse Stock Split [Member]
Pre Reverse Stock Split [Member]
Promissory Note [Member]
Reclassifications policy.
Remaining shares converted.
Revaluation of restricted stock units between additional paid in capital and deferred compensation.
Revaluation of warrant liability upon conversion of Convertible Preferred Stock.
Amount of security deposit offset against accounts payable.
Series A Notes Payable Due At Maturity In October Two Thousand Eleven [Member]
The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of equity instruments other than options outstanding and currently exercisable.
Weighted average price at which grantees could have acquired the underlying shares with respect to equity instruments other than options of the plan that expired.
Weighted average per share amount at which grantees can acquire shares of common stock by exercise equity instruments other than options.
Weighted average remaining contractual term for vested portions of equity instruments other than options outstanding and currently exercisable or convertible, in ''PnYnMnDTnHnMnS'' format, for example, ''P1Y5M13D'' represents the reported fact of one year, five months, and thirteen days.
Weighted average price at which grantees can acquire the shares reserved for issuance.
The number of non option shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted.
Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of equity instruments other than options outstanding and currently exercisable.
Stock Option 2003 Plan [Member]
Stock Option 2013 Plan [Member]
Subscription Agreement [Member]
Verify Me [Member]
Warrant value.
Warrants issued as discount to notes payable.
Warrants Issued On January 12014 [Member]
Zaah Technologies [Member]
Value of common stock - to be issued.
Gain loss on settlement of related party notes payable.
Gain loss on debt forgiveness.
The fair value of restricted stock issued for services.
Exercise of Stock Options.
Patents And Trademark [Member]
Number of patents granted.
Number of trademarks.
Number of new patent.
Transaction One [Member]
Common Stock payable [Member]
Stock Option 2017 Plan [Member]
Employee [Member]
Board of Directors, CEO, Employee [Member]
Board of Directors, CFO, Employee [Member]
Chairman of Board [Member]
Vesting immediately [Member]
Vest over a period of two years [Member]
Vesting over a six month period [Member]
Employees [Member]
Series C Convertible Preferred Stock [Member]
Series D Convertible Preferred Stock [Member]
Sale of units [Member]
Related party note payables [Member]
Issaunce of notes payable [Member]
It represents description related to exercise price of stock options.
Unamortized option expense.
Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract]
Number of non-option equity instruments issued by participants.
The number of shares into which fully or partially vested equity instruments other than options outstanding and expected to vest as of the balance sheet date can be currently converted under the option plan.
Weighted average price at which grantees could have acquired the underlying shares with respect to equity instruments other than options of the plan that issued.
Weighted average price at which option holders acquired shares when converting their equity instruments other than options into shares.
Weighted average price at which grantees could have acquired the underlying shares with respect to equity instruments other than options that were terminated.
The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on exercisable and expected to vest portions of equity instruments other than options outstanding and currently exercisable under the plan.
Weighted average remaining contractual term for vested portions of equity instruments other than options outstanding and currently exercisable or expected to vest, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of equity instruments other than options outstanding and currently exercisable and expected to vest.
Consulting service agreement [Member]
Warrant term.
Issuance of shares cashless exercise of options related to services.
Amount of Settlement paid.
Settlement Agreement [Member]
Fair value inputs, expected term.
Fair value inputs, expected dividend rate.
Fair value inputs, expected volatility rate.
Fair value inputs, risk free interest rate.
Settlement agreement with shareholders.
Weighted average estimated fair value of options during the period.
Disposed shares related to services.
Related Party [Member]
Third Party [Member]
Debt forgiveness.
Former Chief Executive Officer [Member]
New Director [Member]
Klapper [Member]
Warrant discount program [Member]
Member of Board [Member]
Assets, Current
Assets
Liabilities, Current
Treasury Stock, Value
Deferred Compensation Equity
Stockholders' Equity Attributable to Parent
Liabilities and Equity
Gross Profit
Operating Expenses
Operating Income (Loss)
Nonoperating Income (Expense)
Weighted Average Number of Shares Outstanding, Basic
Weighted Average Number of Shares Outstanding, Diluted
Increase (Decrease) in Inventories
Increase (Decrease) in Prepaid Expense
Increase (Decrease) in Accounts Payable and Accrued Liabilities
Net Cash Provided by (Used in) Operating Activities
Payments to Acquire Intangible Assets
Net Cash Provided by (Used in) Investing Activities
Net Cash Provided by (Used in) Financing Activities
Cash and Cash Equivalents, Period Increase (Decrease)
Schedule of Debt [Table Text Block]
Notes Payable
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares
Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable And Expected To Vest
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedWeightedAverageExercisePrice
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercises in Period Weighted Average Exercise Price
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants in Period Weighted Average Exercise Price
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercises In Period Weighted Average Exercise Price
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Exercise Price
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable And Expected To Vest Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Exercisable Weighted Average Remaining Contractual Terms
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Exercisable And Expected To Vest Weighted Average Remaining Contractual Terms
Sharebased Compensation Arrangement By Sharebased Payment Award Other Than Options Exercisable Intrinsic Value1
Sharebased Compensation Arrangement By Sharebased Payment Award Other Than Options Exercisable And Expected To Vest Intrinsic Value
Debt Instrument, Decrease, Forgiveness